Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Shenzhen Stock Exchange 000766.SZ

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Capital Expenditure for the year ending December 31, 2023: USD -3.76 M

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Capital Expenditure is USD -3.76 M for the year ending December 31, 2023, a -9.18% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Capital Expenditure for the year ending December 31, 2022 was USD -3.44 M, a 14.20% change year over year.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Capital Expenditure for the year ending December 31, 2021 was USD -4.01 M, a -36.62% change year over year.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Capital Expenditure for the year ending December 31, 2020 was USD -2.93 M, a 66.49% change year over year.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Capital Expenditure for the year ending December 31, 2019 was USD -8.76 M, a 19.05% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Shenzhen Stock Exchange: 000766.SZ

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

CEO	Mr. Hongjun Zhan Ph.D.
IPO Date	April 30, 1997
Location	China
Headquarters	No. 999, Jinma Road
Employees	1,696
Sector	Health Care
Industries Pharmaceuticals

Description

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products primarily focus on the rheumatism, digestion, cancer, and gynecology fields. The company offers traditional Chinese medicines, such as gynecological, rheumatic and bone pain, urology, detoxification, cardio-cerebral, digestive, respiratory, diabetes, and pediatric medication products, as well as anti-tumor drugs, prescription and OTC drugs, and Western medicines. The company offers its products in the form of capsules, tablets, injections, liquids, etc. Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. was founded in 1990 and is based in Tonghua, China.

Key trends

Past 5 years